Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98149865 | 9814986 | 5 | F | 20140106 | 20160919 | 20140114 | 20160923 | EXP | CA-ROCHE-1332793 | ROCHE | 19.61 | YR | F | Y | 0.00000 | 20160923 | MD | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 98149865 | 9814986 | 1 | PS | XOLAIR | OMALIZUMAB | 1 | Subcutaneous | U | 103976 | 375 | MG | SOLUTION FOR INJECTION | QOW |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 98149865 | 9814986 | 1 | Asthma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 98149865 | 9814986 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 98149865 | 9814986 | Clostridium difficile infection | |
| 98149865 | 9814986 | Concomitant disease aggravated | |
| 98149865 | 9814986 | Cystic fibrosis | |
| 98149865 | 9814986 | Dyspnoea | |
| 98149865 | 9814986 | General physical condition abnormal | |
| 98149865 | 9814986 | Lower respiratory tract infection | |
| 98149865 | 9814986 | Lung infection | |
| 98149865 | 9814986 | Malaise | |
| 98149865 | 9814986 | Pneumonia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 98149865 | 9814986 | 1 | 20090506 | 0 |